Skip to main content

Advertisement

  • Research
  • Open Access

Tetramethylpyrazine exerts a protective effect against injury from acute myocardial ischemia by regulating the PI3K/Akt/GSK-3β signaling pathway

  • †1,
  • †2,
  • 1,
  • 1,
  • 1,
  • 1 and
  • 3Email author
†Contributed equally
Cellular & Molecular Biology Letters201924:17

https://doi.org/10.1186/s11658-019-0141-5

©  The Author(s) 2019

  • Received: 12 September 2018
  • Accepted: 11 February 2019
  • Published:

Abstract

Objective

We investigated the protective effect of tetramethylpyrazine (TMP) on injury related to acute myocardial ischemia (AMI) induced by isoproterenol (ISO).

Materials and methods

Rats were randomly assigned to five groups: control, ISO, ISO + propranolol (10 mg/kg), ISO + TMP (10 mg/kg) and ISO + TMP (20 mg/kg). The rats in the three ISO + groups were pretreated with propranolol or TMP, while the rats in the control and ISO groups were pretreated with an equal volume of saline. Afterwards, the rats in the four administration groups were subcutaneously injected with ISO for two consecutive days. The levels of creatine kinase (CK), lactate dehydrogenase (LDH), superoxide dismutase (SOD), malondialdehyde (MDA), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and IL-1β in the serum were measured using ELISA. The expressions of B-cell lymphoma-associated X-2 (Bax-2), B-cell lymphoma-2 (Bcl-2), phosphoinositide-3-kinase (PI3K), protein kinase B (Akt), glycogen synthase kinase 3β (GSK-3β), MDA5 and SOD1 were determined using western blotting assay. The phosphorylation of PI3K, Akt and GSK-3β were also determined using western blotting assay. The left ventricles of the rats were extracted and stained using hematoxylin and eosin (H&E). The ST segment was recorded using electrocardiograms (ECGs).

Results

Administration of TMP (10, 20 mg/kg) reduced the levels of MDA and CK and the activities of SOD and LDH in the serum. Pretreatment with TMP significantly reduced the levels of pro-inflammatory cytokines, including IL-1β, IL-6 and TNF-α. Treatment with TMP also improved the histopathological alteration and decreased the ST elevation. Furthermore, TMP ameliorated the expressions of Cu, SOD1, MDA5, Bax-2, Bcl-2, p-PI3K, p-Akt and p-GSK-3β in ISO-induced rats.

Conclusions

Tetramethylpyrazine protected against injury due to AMI by regulating the PI3K/Akt /GSK-3β signaling pathway.

Keywords

  • Tetramethylpyrazine
  • Myocardial ischemia
  • PI3K
  • Akt
  • GSK-3β

Introduction

The leading cause of morbidity in the Western world is acute myocardial ischemia (AMI), which is caused by an imbalance between the blood supply to the heart and the demand of the myocardium [1, 2]. The primary features of AMI are hypoxia, cell ischemia and inflammation. Obstruction of the blood flow to the heart contributes to the ischemia of myocardial cells, which may contribute to the apoptotic process [3–5]. Despite significant research and clinical advances, there have been no fundamental breakthroughs in drug treatment [6].

Isoproterenol (ISO), a β-adrenergic agonist, is known to induce AMI due to autoxidation-related free radical production [7]. ISO-induced AMI increases the levels of cardiac enzymes and oxidative stress, and results in abnormal electrocardiograph and cardiac functions [8].

Although the pathogenesis of AMI is far from clear, the anatomical changes and biochemical markers have been well characterized. Overproduction of reactive oxygen species (ROS) and activation of inflammatory cascades are the major causative factors of cardiomyocyte abnormalities [9, 10]. Activation of the pro-survival kinase-signaling cascade phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) promotes cell survival and recruits the anti-apoptotic pathway during reperfusion [11, 12].

Experimental studies have indicated that intervention and ischemia preconditioning using some pharmacological agents can recruit the PI3K/Akt pathway and confer powerful cardioprotection [13]. It has been proposed that pharmacological targeting of the Akt pathway may potentially diminish ischemia reperfusion (IR) injury [14].

Glycogen synthase kinase-3β (GSK-3β) belongs to a family of conserved serine/threonine kinases. Its activity is regulated by the PI3K/Akt, extracellular signal-regulated kinase (ERK1/2) and Wnt/wingless signaling pathways, among others [15]. GSK-3β phosphorylation at Ser9 causes its N-terminal protein tail to act as a pre-phosphorylated substrate, leading to GSK-3β inactivation [16]. The selective inhibition of GSK-3β has been shown to exert cardioprotective effects by maintaining mitochondrial function during ischemia/reperfusion injury [17].

Tetramethylpyrazine (TMP) is an alkaloid found in the roots of Ligusticum chuanxiong Hort (Fig. 1) [18]. It has cardioprotective effects against myocardial IR injury: it limits infarct size and reduces apoptosis [19]. In this study, we further investigated the cardioprotective effect of TMP and assessed whether the PI3K/Akt/GSK-3β signal pathway was involved in the cardioprotective effect of TMP.
Fig. 1
Fig. 1

Molecular formula of tetramethylpyrazine (TMP)

Materials and methods

Materials

This study was performed in accordance with the National Institutes of Health Guidelines for the Use of Laboratory Animals. Male Sprague-Dawley (SD) rats (200–220 g) were provided by Shanghai Slac Laboratory Animal Co. Ltd. All animals were allowed free access to food and water, and were maintained at 22–24 °C under a 12 h:12 h light–dark cycle.

Tetramethylpyrazine (TMP; Fig. 1) and isoproterenol (ISO) were obtained from National Institutes for Food and Drug Control in Beijing. Tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and IL-1β ELISA kits, creatine kinase (CK), lactate dehydrogenase (LDH), and ELISA kits for the detections of malondialdehyde (MDA) and total superoxide dismutase (T-SOD) were produced by Jiancheng Bioengineering Institute.

Experimental protocol

Rats were randomly assigned to the control group and four administration groups: ISO, ISO + propranolol (10 mg/kg), ISO + TMP (10 mg/kg), and ISO + TMP (20 mg/kg). There were 10 rats in each group. The rats in the three ISO + groups were pretreated with propranolol or TMP, while the rats in the control and ISO groups were treated with equal volumes of normal saline. Afterwards, the rats in all four administration groups were subcutaneously injected with ISO (85 mg/kg) for two consecutive days [20]. Blood (3 ml) was collected from the abdominal aorta for serum enzyme assays. After treatment, three hearts from each group were weighed and applied for the western blotting assay. Three hearts from each group were rinsed in ice-cold isotonic saline, blotted with filter paper, and homogenized in 0.05 M ice-cold phosphate buffer (pH 7.4) for biochemical assays.

Evaluation of ST segment elevation

Electrocardiograms (ECGs) recorded ST segment elevation 24 h after the final injection of ISO or other drugs. ECGs were recorded under 3% chloral hydrate anesthesia using needle electrodes and a BL-420S Biological Function Experiment System purchased from Chengdu Thaimeng Technology Co. Ltd.

Calculation of the heart weight index

The heart tissues were weighed after blotting with filter paper. The heart weight index (HWI) was calculated as heart weight (HW)/bodyweight (BW).

Determinations of CK, LDH, SOD, MDA, TNF-α, IL-6 and IL-1β in serum

Blood samples were collected from the carotid artery and centrifuged at 3500 rpm for 15 min. Then the supernatants were obtained and preserved at − 80 °C for serum enzyme assays and cytokine analyses. IL-6, IL-1β and TNF-α were analyzed using ELISA kits. The levels of CK, LDH, SOD and MDA were measured using a rate assay. All measurements were performed according to the kit manufacturers’ instructions.

Histological examination of the myocardium

Immediately after removal, the hearts were fixed in 10% formalin solution. The heart tissue was processed for sectioning and staining using standard histological methods. Sections from the left ventricle were stained using hematoxylin and eosin (H&E).

Western blotting

Total proteins were extracted from myocardial tissues using ice-cold RIPA lysis buffer. Dissolved proteins were collected and the debris was removed via centrifugation at 12,000 rpm for 5 min at 4 °C. The concentration of total protein was determined using bicinchoninic acid protein assay reagent. Equal amounts of isolated protein were loaded on SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto the polyvinylidene difluoride (PVDF) membrane. The membranes were incubated at 4 °C overnight with 5% skim milk in Tris buffer saline for blocking. After the membranes were blocked, they were incubated with monoclonal antibodies against Bax-2, Bcl-2, PI3K, Akt, GSK-3β, p-PI3K, p-Akt, p-GSK-3β, MDA5, SOD1 and GAPDH (all from Cell Signaling Technology). After washing with TBST three times, they were incubated with horseradish peroxidase-conjugated IgGs (1:10000; Bioworld Biotechnology) for 1 h at room temperature. Target proteins were detected using the ECL system (Millipore) and visualized with the ChemiDoc XRS system (Bio-Rad).

Statistical analysis

Each experiment was repeated at least three times. Data are shown as the means ± standard deviation, and were analyzed using SPSS 18.0. Statistical comparisons between groups were analyzed using two-tailed Student’s t test or one-way ANOVA. p < 0.05 is considered to indicate a statistically significant difference.

Results

TMP reduces ST segment elevation

In our study, the ST segment was dramatically elevated in the ISO-stimulated rats. These results suggest that the myocardial ischemia damage model was successfully established. However, the ST segment was obviously decreased in the groups treated with TMP or propranolol compared with those in the ISO group (Fig. 2).
Fig. 2
Fig. 2

Statistical analysis of tetramethylpyrazine (TMP) on ST segment elevation. Values are expressed as means ± SD. ##p < 0.01 compared to control, **p < 0.01 compared to ISO group. Control: rats pretreated with saline solution. ISO: rats pretreated with saline solution and treated with isoproterenol (ISO). ISO + Pro: rats pretreated with propranolol (Pro) and treated with ISO. ISO + TMP: rats pretreated with indicated dosage of TMP and treated with ISO

TMP decreases the levels of TNF-α, IL-6 and IL-1β

We also found that the levels of the pro-inflammatory cytokines TNF-α, IL-6 and IL-1β in the serum were significantly increased in ISO rats compared with the control group. However, pretreatment with TMP decreased the levels of TNF-α, IL-6 and IL-1β relative to the levels for untreated rats in a dose-dependent manner (Fig. 3).
Fig. 3
Fig. 3

The effects of tetramethylpyrazine (TMP) on the levels of pro-inflammatory cytokines IL-1β, IL-6 and TNF-α in serum were detected using ELISA assays. Values are expressed as means ± SD. ##p < 0.01compared to control group; *p < 0.05, **p < 0.01 compared to ISO group. Control: rats pretreated with saline solution. ISO: rats pretreated with saline solution and treated with isoproterenol (ISO). ISO + Pro: rats pretreated with propranolol (Pro) and treated with ISO. ISO + TMP: rats pretreated with indicated dosage of TMP and treated with ISO

TMP decreases CK and LDH serum levels

The serum levels of CK and LDH, which are marker enzymes of myocardial injury, were also examined. The levels of CK and LDH increased in the ISO group in comparison with those in the control group (Fig. 4a and b). Propranolol could decrease the contents of CK and LDH. Pretreatment with TMP decreased CK and LDH levels compared with the levels for rats in the ISO group in a dose-dependent manner.
Fig. 4
Fig. 4

The effects of tetramethylpyrazine (TMP) on the levels of creatine kinase (CK), lactate dehydrogenase (LDH), superoxide dismutase (SOD) and malondialdehyde (MDA) in the serum. a The effects of TMP on the levels of LDH in the serum were analyzed using ELISA. b The effects of TMP on the levels of CK in the serum were analyzed using ELISA. c The effects of TMP on the levels of SOD in the serum were analyzed using ELISA. d The effects of TMP on the levels of MDA in the serum were analyzed using ELISA. Control: rats pretreated with saline solution. ISO: rats pretreated with saline solution and treated with isoproterenol (ISO). ISO+Pro: rats pretreated with propranolol (Pro) and treated with ISO. ISO+TMP: rats pretreated with indicated dosage of TMP and treated with ISO.Values are expressed as means ± SD. ##p < 0.01 compared to control group; *p < 0.05, **p < 0.01 compared to ISO group

TMP decreases SOD and MDA serum levels

To determine whether TMP attenuated the oxidation index, the levels of SOD and MDA in the serum were measured. Compared with the control group, SOD levels in the ISO group were significantly downregulated by TMP (Fig. 4c). However, pretreatment with TMP markedly increased the level of SOD (Fig. 4c) and reduced the MDA level (Fig. 4d) in a dose-dependent manner. These data suggest that TMP significantly enhanced the activities of the enzymatic antioxidant defense system.

TMP decreases heart weight indices

Heart weight indices (HWIs) were measured to assess injury due to acute myocardial ischemia (AMI). The HWIs for the ISO group rats were higher than those for the control group rats. Pretreatment with TMP decreased the HWIs compared with those for the ISO group rats (Fig. 5).
Fig. 5
Fig. 5

Effects of tetramethylpyrazine (TMP) on heart weight indices. Values are expressed as means ± SD. ##p < 0.01 compared to control group; *p < 0.05, **p < 0.01 compared to ISO group. Control: rats pretreated with saline solution. ISO: rats pretreated with saline solution and treated with isoproterenol (ISO). ISO + Pro: rats pretreated with propranolol (Pro) and treated with ISO. ISO + TMP: rats pretreated with indicated dosage of TMP and treated with ISO

TMP attenuates the histopathological condition of myocardial tissue

Hematoxylin and eosin (H&E) staining was carried out to evaluate the protective role of TMP. Light microscopy of tissue sections from control rat myocardia showed a normal myofibrillar structure with striations, a branched appearance and continuity with adjacent myofibrils. The pathology assessment of the myocardia of ISO rats revealed obvious myocardial cell swelling, degeneration, transverse striation loss and inflammatory cell infiltration. Tissues from rats pretreated with TMP showed normal, well preserved cardiac muscle cell histology. Tissue sections from the propranolol group rats revealed approximately normal myofibrillar structure with clear transverse striations and the presence of a few inflammatory cells (Fig. 6). The results indicate that TMP could attenuate the histopathological condition in myocardial tissue.
Fig. 6
Fig. 6

Effects of TMP on myocardial histology. a Control group. b ISO group (rats pretreated with saline solution and treated with ISO). c ISO + Pro group (rats pretreated with propranolol (Pro) and treated with ISO). d ISO + TMP (10 mg/kg) group (rats pretreated with 10 mg/kg TMP and treated with ISO). e ISO + TMP (20 mg/kg) group (rats pretreated with 20 mg/kg TMP and treated with ISO)

TMP decreases the levels of MDA5 and increases the levels of SOD1

ISO also changed the protein expressions of SOD1 and MDA5 in heart tissue. Compared with the control group, the protein levels of MDA5 in the ISO group were significantly higher (Fig. 7). In the TMP-pretreated group, the protein levels of MDA5 were significantly lower. Compared with the control group, the protein levels of SOD1 in the ISO group were significantly lower. In the TMP-pretreated group, the protein levels of SOD1 were significantly higher than in the ISO group. The results confirmed the anti-oxidative effect of TMP on ISO-induced AMI.
Fig. 7
Fig. 7

The effects of tetramethylpyrazine (TMP) on the expression of SOD1 (A) and MDA5 (B) were measured using a western blotting assay. Values are expressed as means ± SD. #p < 0.05, ##p < 0.01 compared to control group. *p < 0.05, **p < 0.01compared to ISO group. Control: rats pretreated with saline solution. ISO: rats pretreated with saline solution and treated with isoproterenol (ISO). ISO + Pro and Pro: rats pretreated with propranolol (Pro) and treated with ISO. ISO + TMP: rats pretreated with indicated dosage of TMP and treated with ISO

TMP decreases Bax-2 levels and increases PI3K, Akt, GSK-3β and Bcl-2 levels

To further investigate the potential protective mechanism, the impact of TMP on PI3K/Akt/GSK-3β signaling was determined using western blotting assay. The expressions of Bcl-2, p-PI3K, p-Akt and p-GSK-3β in the myocardia of ISO rats were significantly downregulated in contrast with those in the control group (Fig. 8). In the TMP-pretreated group, the protein levels of Bcl-2, p-PI3K, p-Akt and p-GSK-3β significantly increased in a dose-dependent manner compared to the levels for the model group.
Fig. 8
Fig. 8

The effects of tetramethylpyrazine (TMP) on the PI3K/Akt/GSK-3β pathway. The phosphorylation of PI3K, Akt and GSK-3 were detected using a western blotting assay. The expression of Bax-2, Bcl-2, PI3K, Akt, GSK-3β, MDA5 and SOD1 were detected using a western blotting assay. Values are expressed as means ± SD. #p < 0.05, ##p < 0.01 compared to control group. *p < 0.05, **p < 0.01compared to ISO group. Control: rats pretreated with saline solution. ISO: rats pretreated with saline solution and treated with isoproterenol (ISO). ISO + Pro and Pro: rats pretreated with propranolol (Pro) and treated with ISO. ISO + TMP: rats pretreated with indicated dosage of TMP and treated with ISO

Discussion

During acute myocardial ischemia (AMI), ST segment elevation is closely associated with myocardial blood flow, oxygen tension and the contraction rate. Myocardial ischemia induced by coronary artery ligation in rats shows very similar characteristics and can be used as a model of AMI [21]. ST segment elevation is the most straightforward way to identify myocardial ischemia, as shown in the records of electrocardiographs (ECGs) in this study. In our tetramethylpyrazine (TMP) groups, the ST segment was effectively attenuated, suggesting that TMP has a positive influence on cardiac electrical activity.

Creatine kinase (CK) and lactate dehydrogenase (LDH) are identified as essential serum biomarkers for the diagnosis of AMI [22]. The abnormal myocardial energy metabolism seen during AMI elevates the CK level in the serum [23]. Myocardial necrosis enhances the membrane permeability that leads to excessive release of LDH [24]. Our results show that TMP pretreatment potently reduced the levels of LDH and CK after MI was induced. These findings aligned with the histological evaluation of myocardial tissues.

Enhanced levels of inflammatory markers are related to ischemia [25, 26]. Pro-inflammatory cytokines, such as IL-6, IL-1β and TNF-α, are small secreted proteins that mediate and regulate inflammation [27]. In our study, TMP decreased the levels of pro-inflammatory cytokines, suggesting that the cardioprotective effects were related to anti-inflammatory properties.

Superoxide dismutase (SOD) is an important antioxidant enzyme that reflects the capacity of the cell to scavenge free radicals [28]. Under physiological conditions, low levels of reactive oxygen species play important roles in signal transduction and metabolic pathways. However, under pathological conditions, excessive reactive oxygen species result in an imbalance of the antioxidant system. It was proposed that malondialdehyde (MDA) caused injury to the mitochondria and lysosome [29]. SOD1 scavenges superoxide anion to prevent oxygen stress injury and facilitates the generation of SOD [30]. Similarly, the antioxidant protein MDA5 promotes the production of MDA. SOD1 gains importance in the development of heart failure. The alterations in SOD, SOD1, MDA and MDA5 levels support our hypothesis that the cardioprotective effects of TMP in ISO-induced AMI are related to anti-oxidative properties [31].

As part of the intrinsic apoptosis pathway, the Bcl-2 protein family is an important regulator during cardiomyocyte apoptosis [32]. The anti-apoptotic protein, Bcl-2, and survivin have been shown to block the release of cytochrome c from the mitochondria, inhibit caspase activity, and decrease cell apoptosis [33]. Therefore, the balance in apoptotic signaling is influenced by the Bcl-2-to-Bax ratio. Western blotting revealed that TMP increased Bcl-2 and decreased Bax-2 levels, suggesting that TMP-mediated cardioprotection against acute myocardial ischemia injury may occur partially via modulation of Bcl-2 and Bax expression.

Activation of the pro-survival kinase-signaling cascade PI3K/Akt at the time of reperfusion promotes cell survival and recruits the anti-apoptotic pathway during reperfusion [34]. Experimental studies have indicated that the intervention and ischemia preconditioning of some pharmacological agents can recruit the PI3K/Akt pathway and confer powerful cardioprotection [35]. The serine/threonine survival kinase GSK-3β is a point of downstream convergence for PI3K/Akt and Wnt signaling. It is known that ischemic pre- and post-conditioning activate PI3K/Akt and promote the phosphorylation of target molecules, such as GSK-3β, that are downstream of insulin receptor substrates [36]. As depicted in Fig. 7, the expressions of Bax-2 in the myocardia of the ISO rats were significantly upregulated in contrast with those in control group. Compared with the control group, the protein levels of PI3K, Akt, GSK-3β and Bcl-2 in ISO group were significantly lower. In groups with TMP pretreatment, the protein levels of PI3K, Akt, GSK-3β and Bcl-2 significantly increased in a dose-dependent manner compared to the ISO group.

Conclusion

ISO-induced AMI could be attenuated by TMP through regulation of the inflammatory condition and oxidative stress. Our study also demonstrated that TMP exerted cardioprotective effects via regulation of the PI3K/Akt/GSK-3β pathway.

Notes

Abbreviations

AMI: 

Acute myocardial ischemia

CGs: 

Electrocardiograms

CK: 

Creatine kinase

H&E: 

Hematoxylin and eosin

IL-1β: 

Interleukin-1 beta

IL-6: 

Interleukin-6

ISO: 

Isoproterenol

LDH: 

Lactate dehydrogenase

MDA: 

Malondialdehyde

SOD: 

Superoxide dismutase

TMP: 

Tetramethylpyrazine

TNF-α: 

Tumor necrosis factor-alpha

Declarations

Funding

The study was supported by the Key Project of Natural Science Research from Education Office of Sichuan province (No. 16ZA0230).

Availability of data and materials

Not applicable

Authors’ contributions

QY, DDH, DGL and BC designed the study and conducted the experiments. LMZ, CLY and HHH analyzed the data and wrote the manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate

The research protocol was assessed and approved by the Ethics Committee (No: 20171009) of No.1 Hospital of Jilin University.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Blood Transfusion Department, First Hospital of Jilin University, Changchun, Jilin, China
(2)
Preclinical School of North Sichuan Medical College, Nanchong, Sichuan, China
(3)
Faculty of Chinese Medical Science, Guangxi University of Chinese Medicine, No. 13 Wuhe Road, Qingxiu District, Nanning, 530222, Guangxi, China

References

  1. Spartalis M, Voudris V, Iliopoulos DC, Spartalis E, Siasos G. Acute transient myocardial ischemia: a common pathophysiological mechanism in takotsubo syndrome. Is it still a cardiomyopathy? J Cardiol. 2018;72:176.View ArticleGoogle Scholar
  2. Li B, Hu J, Chen X. MicroRNA-30b protects myocardial cell function in patients with acute myocardial ischemia by targeting plasminogen activator inhibitor-1. Exp. Ther. Med. 2018;15:5125–32.PubMedPubMed CentralGoogle Scholar
  3. Kohlhauer M, Dawkins S, Costa ASH, Lee R, Young T, Pell VR, Choudhury RP, Banning AP, Kharbanda RK, Oxford Acute Myocardial Infarction S, Saeb-Parsy K, Murphy MP, Frezza C, Krieg T, Channon KM. Metabolomic Profiling in Acute ST-Segment-Elevation Myocardial Infarction Identifies Succinate as an Early Marker of Human Ischemia-Reperfusion Injury. J Am Heart Assoc. 2018;7:e007546.Google Scholar
  4. Sun Q, Shen ZY, Duan WN, Meng QT, Xia ZY. Mechanism of myocardial ischemia/reperfusion-induced acute kidney injury through DJ-1/Nrf2 pathway in diabetic rats. Exp. Ther. Med. 2017;14:4201–7.PubMedPubMed CentralGoogle Scholar
  5. Li X, Dai Y, Yan S, Shi Y, Han B, Li J, Cha L, Mu J. Down-regulation of lncRNA KCNQ1OT1 protects against myocardial ischemia/reperfusion injury following acute myocardial infarction. Biochem Biophys Res Commun. 2017;491:1026–33.View ArticleGoogle Scholar
  6. Liang S, Ping Z, Ge J. Coenzyme Q10 regulates Antioxidative stress and autophagy in acute myocardial ischemia-reperfusion injury. Oxidative Med Cell Longev. 2017;2017:9863181.Google Scholar
  7. Jia G, Zao M, Liu X. Protective effect of diethylcarbamazine inhibits NF-kappaB activation in isoproterenol-induced acute myocardial infarction rat model through the PARP pathway. Mol Med Rep. 2017;16:1596–602.View ArticleGoogle Scholar
  8. Allawadhi P, Khurana A, Sayed N, Kumari P, Godugu C. Isoproterenol-induced cardiac ischemia and fibrosis: plant-based approaches for intervention. Phytother Res. 2018;32:1908–32.View ArticleGoogle Scholar
  9. Raedschelders K, Ansley DM, Chen DD. The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther. 2012;133:230–55.View ArticleGoogle Scholar
  10. Zhou T, Chuang CC, Zuo L. Molecular characterization of reactive oxygen species in myocardial ischemia-reperfusion injury. Biomed Res Int. 2015;2015:864946.PubMedPubMed CentralGoogle Scholar
  11. Wang ZG, Wang Y, Huang Y, Lu Q, Zheng L, Hu D, Feng WK, Liu YL, Ji KT, Zhang HY, Fu XB, Li XK, Chu MP, Xiao J. bFGF regulates autophagy and ubiquitinated protein accumulation induced by myocardial ischemia/reperfusion via the activation of the PI3K/Akt/mTOR pathway. Sci Rep. 2015;5:9287.View ArticleGoogle Scholar
  12. Lv X, Xu T, Wu Q, Zhou Y, Huang G, Xu Y, Zhong G. 6-Gingerol activates PI3K/Akt and inhibits apoptosis to attenuate myocardial ischemia/reperfusion injury. Evidence-based complementary and alternative medicine : eCAM. 2018;2018:9024034.Google Scholar
  13. Li X, Bilali A, Qiao R, Paerhati T, Yang Y. Association of the PPARgamma/PI3K/Akt pathway with the cardioprotective effects of tacrolimus in myocardial ischemic/reperfusion injury. Mol Med Rep. 2018;17:6759–67.PubMedGoogle Scholar
  14. Zhang M, Gu WW, Hong XY. Involvement of endothelin 1 in remote preconditioning-induced Cardioprotection through connexin 43 and Akt/GSK-3beta signaling pathway. Sci Rep. 2018;8:10941.View ArticleGoogle Scholar
  15. Hu Z, Hu S, Yang S, Chen M, Zhang P, Liu J, Abbott GW. Remote liver ischemic preconditioning protects against sudden cardiac death via an ERK/GSK-3beta-dependent mechanism. PLoS One. 2016;11:e0165123.View ArticleGoogle Scholar
  16. Weng J, Wang YH, Li M, Zhang DY, Jiang BG. GSK3beta inhibitor promotes myelination and mitigates muscle atrophy after peripheral nerve injury. Neural Regen Res. 2018;13:324–30.View ArticleGoogle Scholar
  17. Jiang H, Xiao J, Kang B, Zhu X, Xin N, Wang Z. PI3K/SGK1/GSK3beta signaling pathway is involved in inhibition of autophagy in neonatal rat cardiomyocytes exposed to hypoxia/reoxygenation by hydrogen sulfide. Exp Cell Res. 2016;345:134–40.View ArticleGoogle Scholar
  18. Wang A, Zhu G, Qian P, Zhu T. Tetramethylpyrazine reduces blood-brain barrier permeability associated with enhancement of peripheral cholinergic anti-inflammatory effects for treating traumatic brain injury. Exp. Ther. Med. 2017;14:2392–400.View ArticleGoogle Scholar
  19. Yang J, Li J, Lu J, Zhang Y, Zhu Z, Wan H. Synergistic protective effect of astragaloside IV-tetramethylpyrazine against cerebral ischemic-reperfusion injury induced by transient focal ischemia. J Ethnopharmacol. 2012;140:64–72.View ArticleGoogle Scholar
  20. Zheng P, Liu J, Mai S, Yuan Y, Wang Y, Dai G. Regulation of signal transducer and activator of transcription 3 and apoptotic pathways by betaine attenuates isoproterenol-induced acute myocardial injury in rats. Hum. Exp. Toxicol. 2015;34:538–47.View ArticleGoogle Scholar
  21. Deng XY, Chen JJ, Li HY, Ma ZQ, Ma SP, Fu Q. Cardioprotective effects of timosaponin B II from Anemarrhenae asphodeloides Bge on isoproterenol-induced myocardial infarction in rats. Chem Biol Interact. 2015;240:22–8.View ArticleGoogle Scholar
  22. Khwaja S, Mahmood T, Siddiqui HH. Effect of ethanolic extract of Cyperus rotundus L against isoprenaline induced cardiotoxicity. Indian J. Exp. Biol. 2016;54:670–5.PubMedGoogle Scholar
  23. Song Y, Zhang C, Wang C, Zhao L, Wang Z, Dai Z, Lin S, Kang H, Ma X. Ferulic acid against cyclophosphamide-induced heart toxicity in mice by inhibiting NF-kappaB pathway. Evid Based Complement Alternat Med. 2016;2016:1261270.PubMedPubMed CentralGoogle Scholar
  24. Zhang T, Yan T, Du J, Wang S, Yang H. Apigenin attenuates heart injury in lipopolysaccharide-induced endotoxemic model by suppressing sphingosine kinase 1/sphingosine 1-phosphate signaling pathway. Chem Biol Interact. 2015;233:46–55.View ArticleGoogle Scholar
  25. Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15:505–22.View ArticleGoogle Scholar
  26. Gasparyan AY. Cardiovascular risk and inflammation: pathophysiological mechanisms, drug design, and targets. Curr Pharm Des. 2012;18:1447–9.View ArticleGoogle Scholar
  27. Wang J, Hu Z, Yang S, Liu C, Yang H, Wang D, Guo F. Inflammatory cytokines and cells are potential markers for patients with cerebral apoplexy in intensive care unit. Exp. Ther. Med. 2018;16:1014–20.PubMedPubMed CentralGoogle Scholar
  28. Jain PG, Mahajan UB, Shinde SD, Surana SJ. Cardioprotective role of FA against isoproterenol induced cardiac toxicity. Mol Biol Rep. 2018;45:1357–65.View ArticleGoogle Scholar
  29. Hermenean A, Ardelean A, Stan M, Herman H, Mihali CV, Costache M, Dinischiotu A. Protective effects of naringenin on carbon tetrachloride-induced acute nephrotoxicity in mouse kidney. Chem Biol Interact. 2013;205:138–47.View ArticleGoogle Scholar
  30. Wei B, You MG, Ling JJ, Wei LL, Wang K, Li WW, Chen T, Du QM, Ji H. Regulation of antioxidant system, lipids and fatty acid beta-oxidation contributes to the cardioprotective effect of sodium tanshinone IIA sulphonate in isoproterenol-induced myocardial infarction in rats. Atherosclerosis. 2013;230:148–56.View ArticleGoogle Scholar
  31. Gao J, Zhong MK, Fan ZD, Yuan N, Zhou YB, Zhang F, Gao XY, Zhu GQ. SOD1 overexpression in paraventricular nucleus improves post-infarct myocardial remodeling and ventricular function. Pflugers Archiv : European journal of physiology. 2012;463:297–307.View ArticleGoogle Scholar
  32. Dong S, Ma W, Hao B, Hu F, Yan L, Yan X, Wang Y, Chen Z, Wang Z. microRNA-21 promotes cardiac fibrosis and development of heart failure with preserved left ventricular ejection fraction by up-regulating Bcl-2. Int. J. Clin. Exp. Pathol. 2014;7:565–74.PubMedPubMed CentralGoogle Scholar
  33. Wang H, Li J, Chi H, Zhang F, Zhu X, Cai J, Yang X. MicroRNA-181c targets Bcl-2 and regulates mitochondrial morphology in myocardial cells. J Cell Mol Med. 2015;19:2084–97.View ArticleGoogle Scholar
  34. Zhang C, Pan S, Aisha A, Abudoukelimu M, Tang L, Ling Y. Recombinant human brain natriuretic peptide regulates PI3K/AKT/mTOR pathway through lncRNA EGOT to attenuate hypoxia-induced injury in H9c2 cardiomyocytes. Biochem Biophys Res Commun. 2018;503:1186–93.View ArticleGoogle Scholar
  35. Wang S, Zhu Y, Qiu R. Shikonin protects H9C2 cardiomyocytes against hypoxia/reoxygenation injury through activation of PI3K/Akt signaling pathway. Biomed Pharmacother. 2018;104:712–7.View ArticleGoogle Scholar
  36. Ponnusamy A, Sinha S, Hyde GD, Borland SJ, Taylor RF, Pond E, Eyre HJ, Inkson CA, Gilmore A, Ashton N, Kalra PA, Canfield AE. FTI-277 inhibits smooth muscle cell calcification by up-regulating PI3K/Akt signaling and inhibiting apoptosis. PLoS One. 2018;13:e0196232.View ArticleGoogle Scholar

Copyright

© The Author(s) 2019

Advertisement

Cellular & Molecular Biology Letters

ISSN: 1689-1392

Contact us